307 related articles for article (PubMed ID: 24710173)
21. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity.
Jeong WI; Park O; Radaeva S; Gao B
Hepatology; 2006 Dec; 44(6):1441-51. PubMed ID: 17133483
[TBL] [Abstract][Full Text] [Related]
22. A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-β and vascular endothelial growth factor signalling.
Liu Y; Wang Z; Wang J; Lam W; Kwong S; Li F; Friedman SL; Zhou S; Ren Q; Xu Z; Wang X; Ji L; Tang S; Zhang H; Lui EL; Ye T
Liver Int; 2013 Apr; 33(4):504-15. PubMed ID: 23279742
[TBL] [Abstract][Full Text] [Related]
23. Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-β1/SMAD Signaling and Autophagy in Hepatic Stellate Cells.
Kataoka S; Umemura A; Okuda K; Taketani H; Seko Y; Nishikawa T; Yamaguchi K; Moriguchi M; Kanbara Y; Arbiser JL; Shima T; Okanoue T; Itoh Y
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948151
[TBL] [Abstract][Full Text] [Related]
24. The multi-kinase inhibitor pazopanib targets hepatic stellate cell activation and apoptosis alleviating progression of liver fibrosis.
Elshal M; Abu-Elsaad N; El-Karef A; Ibrahim TM
Naunyn Schmiedebergs Arch Pharmacol; 2015 Dec; 388(12):1293-304. PubMed ID: 26269412
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice.
Osawa Y; Oboki K; Imamura J; Kojika E; Hayashi Y; Hishima T; Saibara T; Shibasaki F; Kohara M; Kimura K
EBioMedicine; 2015 Nov; 2(11):1751-8. PubMed ID: 26870800
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-223 restricts liver fibrosis by inhibiting the TAZ-IHH-GLI2 and PDGF signaling pathways via the crosstalk of multiple liver cell types.
Wang X; Seo W; Park SH; Fu Y; Hwang S; Rodrigues RM; Feng D; Gao B; He Y
Int J Biol Sci; 2021; 17(4):1153-1167. PubMed ID: 33867837
[No Abstract] [Full Text] [Related]
27. β-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis.
Kocabayoglu P; Lade A; Lee YA; Dragomir AC; Sun X; Fiel MI; Thung S; Aloman C; Soriano P; Hoshida Y; Friedman SL
J Hepatol; 2015 Jul; 63(1):141-7. PubMed ID: 25678385
[TBL] [Abstract][Full Text] [Related]
28. NP603, a novel and potent inhibitor of FGFR1 tyrosine kinase, inhibits hepatic stellate cell proliferation and ameliorates hepatic fibrosis in rats.
Lin N; Chen S; Pan W; Xu L; Hu K; Xu R
Am J Physiol Cell Physiol; 2011 Aug; 301(2):C469-77. PubMed ID: 21543745
[TBL] [Abstract][Full Text] [Related]
29. Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways.
Li J; Li X; Xu W; Wang S; Hu Z; Zhang Q; Deng X; Wang J; Zhang J; Guo C
Liver Int; 2015 Apr; 35(4):1222-33. PubMed ID: 25040634
[TBL] [Abstract][Full Text] [Related]
30. Fibronectin Type III Domain-Containing 5 Attenuates Liver Fibrosis Via Inhibition of Hepatic Stellate Cell Activation.
Zhou B; Ling L; Zhang F; Liu TY; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
Cell Physiol Biochem; 2018; 48(1):227-236. PubMed ID: 30007970
[TBL] [Abstract][Full Text] [Related]
31. Praziquantel ameliorates CCl
Liu J; Kong D; Qiu J; Xie Y; Lu Z; Zhou C; Liu X; Zhang R; Wang Y
Br J Pharmacol; 2019 Dec; 176(24):4666-4680. PubMed ID: 31412137
[TBL] [Abstract][Full Text] [Related]
32. STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib.
Deng YR; Ma HD; Tsuneyama K; Yang W; Wang YH; Lu FT; Liu CH; Liu P; He XS; Diehl AM; Gershwin ME; Lian ZX
J Autoimmun; 2013 Oct; 46():25-34. PubMed ID: 23948302
[TBL] [Abstract][Full Text] [Related]
33. Treatment with 4-methylpyrazole modulated stellate cells and natural killer cells and ameliorated liver fibrosis in mice.
Yi HS; Eun HS; Lee YS; Jung JY; Park SH; Park KG; Choi HS; Suh JM; Jeong WI
PLoS One; 2015; 10(5):e0127946. PubMed ID: 26024318
[TBL] [Abstract][Full Text] [Related]
34. Role of TGF-β signaling in differentiation of mesothelial cells to vitamin A-poor hepatic stellate cells in liver fibrosis.
Li Y; Lua I; French SW; Asahina K
Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(4):G262-72. PubMed ID: 26702136
[TBL] [Abstract][Full Text] [Related]
35. Platelet-Derived Growth Factor Receptor α Contributes to Human Hepatic Stellate Cell Proliferation and Migration.
Kikuchi A; Pradhan-Sundd T; Singh S; Nagarajan S; Loizos N; Monga SP
Am J Pathol; 2017 Oct; 187(10):2273-2287. PubMed ID: 28734947
[TBL] [Abstract][Full Text] [Related]
36. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis.
Wang Y; Gao J; Zhang D; Zhang J; Ma J; Jiang H
J Hepatol; 2010 Jul; 53(1):132-44. PubMed ID: 20447716
[TBL] [Abstract][Full Text] [Related]
37. Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease.
Li X; Yao QY; Liu HC; Jin QW; Xu BL; Zhang SC; Tu CT
J Cell Mol Med; 2017 Oct; 21(10):2370-2385. PubMed ID: 28378526
[TBL] [Abstract][Full Text] [Related]
38. Kaempferol attenuates carbon tetrachloride (CCl
Cao R; Cao C; Hu X; Du K; Zhang J; Li M; Li B; Lin H; Zhang A; Li Y; Wu L; Huang Y
Phytomedicine; 2023 Dec; 121():155125. PubMed ID: 37820466
[TBL] [Abstract][Full Text] [Related]
39. Taurine attenuates activation of hepatic stellate cells by inhibiting autophagy and inducing ferroptosis.
Li S; Ren QJ; Xie CH; Cui Y; Xu LT; Wang YD; Li S; Liang XQ; Wen B; Liang MK; Zhao XF
World J Gastroenterol; 2024 Apr; 30(15):2143-2154. PubMed ID: 38681990
[TBL] [Abstract][Full Text] [Related]
40. Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition.
Kluwe J; Pradere JP; Gwak GY; Mencin A; De Minicis S; Osterreicher CH; Colmenero J; Bataller R; Schwabe RF
Gastroenterology; 2010 Jan; 138(1):347-59. PubMed ID: 19782079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
